MedTrace Logo

Efficacy and Safety Study of Platelets Treated for Pathogen Inactivation and Stored for Up to Seven Days

NCT00261924 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 211

Last updated 2010-04-14

No results posted yet for this study

Summary

Objective: To determine if platelets treated for pathogen inactivation and stored for 6 to 7 days are safe and effective compared to platelets collected by the same method, stored for the same amount of time and not treated for pathogen inactivation.

Conditions

Interventions

DEVICE

Transfusion of Pathogen Inactivated Platelets stored for 6-7 days

pathogen inactivation of platelets for transfusion

Sponsors & Collaborators

  • Cerus Corporation

    lead INDUSTRY

Principal Investigators

  • Larry Corash, M.D. · Cerus Corporation

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-31
Primary Completion
2009-07-31
Completion
2009-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00261924 on ClinicalTrials.gov